1. Canada Stocks

  2. •

    Technology services

  3. •

    Packaged software
Mobio Technologies, Inc.

Mobio Technologies, Inc.

0.10
CAD
+0.01
(+11.11%)
-0.10EPS
8.38MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
0.32
0.05
0.61
0.21
0.19
0.02
- -
- -
- -
- -
- -
- -
- -
0.13
Basic EPS, GAAP
-1.15
-2.56
-6.68
-1.75
-1.58
-0.14
-0.06
-0.02
-0.01
-0.04
-0.01
-0.01
-0.01
-0.1
Free Cash Flow per Basic Share
- -
-2.43
-4.83
-0.32
-0.33
-0.09
-0.04
-0.03
-0.01
-0.01
- -
-0.01
-0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-2.78
2.75
3.06
1.46
0.1
0.02
- -
0.03
0.03
-0.01
-0.02
-0.02
-0.03
-0.01
Tangible Book Value per Share
-2.78
0.92
0.38
0.22
-0.05
0.02
- -
0.03
0.03
-0.01
-0.02
-0.02
-0.03
-0.03
Basic Weighted Avg Shares
- -
1
2
3
3
14
16
29
38
38
38
42
43
106
Sales/Revenue/Turnover
- -
- -
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
14
Operating Margin (%)
-441.41
-5,240.45
-969.94
-624.37
-612.76
-666.18
-1,084.38
-1,822.43
-9,499.75
-1,872.32
-2,484.06
-3,635.94
-11,596.5
-0.45
Depreciation Expense
- -
- -
2
2
2
1
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-2
-10
-5
-5
-2
-1
-1
- -
-1
- -
- -
-1
-11
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-360.36
-5,579.24
-1,100.88
-819.95
-846.31
-660.62
-1,336.79
-1,402.89
-5,176.44
-10,583.85
-2,698.12
-4,655.02
-13,632.44
-76.45
Working Capital
- -
- -
1
1
- -
- -
-1
- -
- -
- -
-1
-1
-1
2
LT Debt
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
5
Total Equity
- -
3
8
4
1
- -
- -
1
2
- -
-1
-1
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-195.4
-75.69
-211.92
-451.89
- -
- -
-22.74
- -
- -
- -
- -
- -

Capital Structure

CAD

•

in mil. unless spec.
Jan'25
Jun'25
Jun'25
ST Debt
1
- -
1
LT Borrowings
- -
3
5
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
43
109
112
Market Capitalization
- -
9
8

Working Capital

CAD

•

in mil. unless spec.
Jan'25
Jun'25
Jun'25
Total Current Assets
- -
3
5
Cash, Cash Equivalents & STI
- -
2
4
Accounts Receivable, Net
- -
1
1
Inventories
- -
- -
- -
Total Current Liabilities
2
2
3
Payables & Accruals
- -
2
2
ST Debt
1
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3,643.99%
24.13%
71.66%
Free Cash Flow
-5.99%
-6.06%
59.02%
Net Income, GAAP
28.09%
95.75%
94.85%
Sales/Revenue/Turnover
-20.02%
0.51%
-33.47%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
3
5
4
3
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.01
2025
-0.01
- -
-0.11
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Laurie Anthony Baggio
Full Time Employees
26
Sector
Technology services
Industry
Packaged software
Address
204-1080 Mainland Street Vancouver BC Canada V6B 2T4
IPO Date
Mar 30, 2000
Website
mobiobrands.com
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
Mobio Technologies Inc. (TSXV: MBO) develops and commercializes innovative diagnostic technologies for the detection of infectious diseases and critical health conditions. The company offers rapid diagnostic tests including the Illumigen-Dx instrument and associated test cartridges for point-of-care applications; molecular diagnostic assays targeting respiratory pathogens, gastrointestinal infections, and sexually transmitted diseases; and digital health platforms for result reporting and telemedicine integration. Founded in 2021 and headquartered in Richmond, British Columbia, Canada, Mobio operates primarily in North America with expansion into European and Asian markets serving clinical laboratories, hospitals, and primary care providers. In late 2024, the company secured a C$10 million strategic funding round led by existing investors to accelerate commercialization of its next-generation PCR-based diagnostics; formed a key partnership with a major Canadian health network for pilot deployments; and launched the Mobio One platform, a cloud-connected system enhancing test throughput by 40%. These developments position Mobio as a leader in decentralized diagnostics amid growing demand for at-home and rapid testing solutions.